{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:30:41Z","timestamp":1790267441727,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T00:00:00Z","timestamp":1497225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T00:00:00Z","timestamp":1497225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>West Nile virus (WNV) is a neurotropic pathogen which causes zoonotic disease in humans. Recently, there have been an increasing number of infected cases and there are no clinically approved vaccines or effective drugs to treat WNV infections in humans. The purpose of this study was to facilitate vaccine and antiviral drug discovery by developing a packaging cell line-restricted WNV infectious replicon particle system. We constructed a DNA-based WNV replicon lacking the C-prM-E coding region and replaced it with a GFP coding sequence. To produce WNV replicon particles, cell lines stably-expressing prM-E and C-prM-E were constructed. When the WNV replicon plasmid was co-transfected with a WNV C-expressing plasmid into the prM-E-expressing cell line or directly transfected the C-prM-E expressing cell line, the replicon particle was able to replicate, form green fluorescence foci, and exhibit cytopathic plaques similar to that induced by the wild type virus. The infectious capacity of the replicon particles was restricted to the packaging cell line as the replicons demonstrated only one round of infection in other permissive cells. Thus, this system provides a safe and convenient reporter WNV manipulating tool which can be used to study WNV viral invasion mechanisms, neutralizing antibodies and antiviral efficacy.<\/jats:p>","DOI":"10.1038\/s41598-017-03670-4","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T11:25:41Z","timestamp":1496748341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["West Nile virus infectious replicon particles generated using a packaging-restricted cell line is a safe reporter system"],"prefix":"10.1038","volume":"7","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Hong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"key":"3670_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","volume":"56","author":"MA Brinton","year":"2002","unstructured":"Brinton, M. A. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol \n                           56, 371\u2013402 (2002).","journal-title":"Annu Rev Microbiol"},{"key":"3670_CR2","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3201\/eid1108.050289a","volume":"11","author":"EB Hayes","year":"2005","unstructured":"Hayes, E. B. et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis \n                           11, 1167\u20131173 (2005).","journal-title":"Emerg Infect Dis"},{"key":"3670_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/jmedent\/43.3.552","volume":"43","author":"MV Fyodorova","year":"2006","unstructured":"Fyodorova, M. V. et al. Evaluation of potential West Nile virus vectors in Volgograd region, Russia, 2003 (Diptera: Culicidae): species composition, bloodmeal host utilization, and virus infection rates of mosquitoes. J Med Entomol \n                           43, 552\u2013563 (2006).","journal-title":"J Med Entomol"},{"key":"3670_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3201\/eid2008.131433","volume":"20","author":"Z Lu","year":"2014","unstructured":"Lu, Z. et al. Human infection with West Nile Virus, Xinjiang, China, 2011. Emerg Infect Dis \n                           20, 1421\u20131423 (2014).","journal-title":"Emerg Infect Dis"},{"key":"3670_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/vbz.2012.0995","volume":"13","author":"XL Li","year":"2013","unstructured":"Li, X. L. et al. West nile virus infection in Xinjiang, China. Vector Borne Zoonotic Dis \n                           13, 131\u2013133 (2013).","journal-title":"Vector Borne Zoonotic Dis"},{"key":"3670_CR6","first-page":"653","volume":"68","author":"GD Huhn","year":"2003","unstructured":"Huhn, G. D., Sejvar, J. J., Montgomery, S. P. & Dworkin, M. S. West Nile virus in the United States: an update on an emerging infectious disease. Am Fam Physician \n                           68, 653\u2013660 (2003).","journal-title":"Am Fam Physician"},{"key":"3670_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","author":"TJ Chambers","year":"1990","unstructured":"Chambers, T. J., Hahn, C. S., Galler, R. & Rice, C. M. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol \n                           44, 649\u2013688 (1990).","journal-title":"Annu Rev Microbiol"},{"key":"3670_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/jcm.22.2.250-254.1985","volume":"22","author":"DM Morens","year":"1985","unstructured":"Morens, D. M., Halstead, S. B., Repik, P. M., Putvatana, R. & Raybourne, N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol \n                           22, 250\u2013254 (1985).","journal-title":"J Clin Microbiol"},{"key":"3670_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","volume":"346","author":"TC Pierson","year":"2006","unstructured":"Pierson, T. C. et al. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology \n                           346, 53\u201365 (2006).","journal-title":"Virology"},{"key":"3670_CR10","doi-asserted-by":"publisher","first-page":"11605","DOI":"10.1128\/JVI.78.21.11605-11614.2004","volume":"78","author":"F Scholle","year":"2004","unstructured":"Scholle, F., Girard, Y. A., Zhao, Q., Higgs, S. & Mason, P. W. trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J Virol \n                           78, 11605\u201311614 (2004).","journal-title":"J Virol"},{"key":"3670_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.virol.2006.02.036","volume":"351","author":"R Fayzulin","year":"2006","unstructured":"Fayzulin, R., Scholle, F., Petrakova, O., Frolov, I. & Mason, P. W. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines. Virology \n                           351, 196\u2013209 (2006).","journal-title":"Virology"},{"key":"3670_CR12","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1128\/AAC.49.12.4980-4988.2005","volume":"49","author":"F Puig-Basagoiti","year":"2005","unstructured":"Puig-Basagoiti, F. et al. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery. Antimicrob Agents Chemother \n                           49, 4980\u20134988 (2005).","journal-title":"Antimicrob Agents Chemother"},{"key":"3670_CR13","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1128\/JVI.72.7.5967-5977.1998","volume":"72","author":"AA Khromykh","year":"1998","unstructured":"Khromykh, A. A., Varnavski, A. N. & Westaway, E. G. Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J Virol \n                           72, 5967\u20135977 (1998).","journal-title":"J Virol"},{"key":"3670_CR14","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1128\/JVI.77.16.8924-8933.2003","volume":"77","author":"R Gehrke","year":"2003","unstructured":"Gehrke, R. et al. Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J Virol \n                           77, 8924\u20138933 (2003).","journal-title":"J Virol"},{"key":"3670_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jviromet.2009.05.016","volume":"161","author":"K Yoshii","year":"2009","unstructured":"Yoshii, K. et al. Establishment of a neutralization test involving reporter gene-expressing virus-like particles of tick-borne encephalitis virus. J Virol Methods \n                           161, 173\u2013176 (2009).","journal-title":"J Virol Methods"},{"key":"3670_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.virusres.2013.02.009","volume":"174","author":"S Sangiambut","year":"2013","unstructured":"Sangiambut, S. et al. Sustained replication of dengue pseudoinfectious virus lacking the capsid gene by trans-complementation in capsid-producing mosquito cells. Virus Res \n                           174, 37\u201346 (2013).","journal-title":"Virus Res"},{"key":"3670_CR17","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1016\/j.vaccine.2014.03.091","volume":"32","author":"X Pang","year":"2014","unstructured":"Pang, X., Guo, Y., Zhou, Y., Fu, W. & Gu, X. Highly efficient production of a dengue pseudoinfectious virus. Vaccine \n                           32, 3854\u20133860 (2014).","journal-title":"Vaccine"},{"key":"3670_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1128\/JVI.78.1.531-538.2004","volume":"78","author":"TJ Harvey","year":"2004","unstructured":"Harvey, T. J. et al. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J Virol \n                           78, 531\u2013538 (2004).","journal-title":"J Virol"},{"key":"3670_CR19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/jcm.4.6.503-510.1976","volume":"4","author":"HS Lindsey","year":"1976","unstructured":"Lindsey, H. S., Calisher, C. H. & Mathews, J. H. Serum dilution neutralization test for California group virus identification and serology. J Clin Microbiol \n                           4, 503\u2013510 (1976).","journal-title":"J Clin Microbiol"},{"issue":"Pt 1","key":"3670_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","volume":"70","author":"CH Calisher","year":"1989","unstructured":"Calisher, C. H. et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol \n                           70(Pt 1), 37\u201343 (1989).","journal-title":"J Gen Virol"},{"key":"3670_CR21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/mab.2014.0047","volume":"33","author":"LP Guo","year":"2014","unstructured":"Guo, L. P., Huo, H., Wang, X. L., Bu, Z. G. & Hua, R. H. Generation and characterization of a monoclonal antibody against prM protein of West Nile virus. Monoclon Antib Immunodiagn Immunother \n                           33, 438\u2013443 (2014).","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"3670_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1472-6750-14-62","volume":"14","author":"RH Hua","year":"2014","unstructured":"Hua, R. H. et al. Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate. BMC Biotechnol \n                           14, 62 (2014).","journal-title":"BMC Biotechnol"},{"key":"3670_CR23","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1099\/vir.0.059436-0","volume":"94","author":"XF Li","year":"2013","unstructured":"Li, X. F. et al. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2. J Gen Virol \n                           94, 2700\u20132709 (2013).","journal-title":"J Gen Virol"},{"key":"3670_CR24","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1128\/JVI.77.23.12901-12906.2003","volume":"77","author":"MK Lo","year":"2003","unstructured":"Lo, M. K., Tilgner, M. & Shi, P. Y. Potential high-throughput assay for screening inhibitors of West Nile virus replication. J Virol \n                           77, 12901\u201312906 (2003).","journal-title":"J Virol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03670-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03670-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03670-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:13:16Z","timestamp":1671772396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03670-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03670-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,12]]},"assertion":[{"value":"10 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3286"}}